Streetbeat News

Analyst Ratings

PSNL

Needham analyst Mike Matson has reiterated a Buy rating on Personalis (NASDAQ:PSNL) and maintained a price target of $2.3.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 6:09 pm

AGL

Truist Securities analyst Jailendra Singh has downgraded Agilon Health (NYSE:AGL) from Buy to Hold and reduced the price target from $23 to $10.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 6:07 pm

APA

Charles Meade, an analyst at Johnson Rice, has downgraded APA Corporation (NASDAQ:APA) from Buy to Hold and set a price target of $40.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 6:05 pm

PB

Prosperity Bancshares (NYSE:PB) has received mixed analyst ratings over the last quarter, with 5 bullish and 3 indifferent ratings. Recent updates show analysts adjusting their 12-month price targets, with an average target of $67.00, up from $63.29. The company operates a community bank model in Texas and has seen a -6.47% decline in revenue growth as of September 30, 2023. Despite this, it maintains a high net margin of 41.97% but has a lower than average ROE of 1.6%. Its ROA of 0.28% and a debt-to-equity ratio of 0.6 reflect strong financial performance and conservative debt management.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 6:01 pm

CMA

Comerica (NYSE:CMA) received mixed ratings from 16 financial analysts in the past three months, with an average 12-month price target of $53.03, reflecting an 8.05% increase from the previous target. Analysts' actions include raising, maintaining, and lowering ratings and price targets, indicating varied perspectives on Comerica's performance. The company faces challenges with a revenue decline of -9.04% over 3 months but shows strong financial health with a high net margin of 27.23% and an ROE of 4.99%. However, its ROA and high debt-to-equity ratio suggest areas of concern.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 6:00 pm

FHN

Six analysts have recently updated their ratings on First Horizon (NYSE:FHN), with a mix of bullish and indifferent stances. The average 12-month price target is now $14.42, up 15.36% from the previous $12.50. Analysts from firms like Raymond James and Wells Fargo have raised their price targets, reflecting a positive shift in expectations for FHN's stock performance. Despite this, First Horizon faces challenges with revenue decline, below-average net margin, ROE, and ROA, although it maintains a healthy debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 6:00 pm

APTV

CVS

GXO

MAR

On CNBC's Halftime Report, analysts shared their final trades, which included stock recommendations for Aptiv PLC, Marriott International, CVS Health Corp, and GXO Logistics.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 6:00 pm

APA

Analysts have provided diverse opinions on APA (NASDAQ:APA) with 11 analysts offering ratings ranging from bullish to bearish. Over the past quarter, sentiments have shifted, with the current average 12-month price target for APA being $45.64, down 11.38% from the previous $51.50. Analysts from firms like Raymond James, UBS, Wells Fargo, Citigroup, RBC Capital, Piper Sandler, Benchmark, Mizuho, Susquehanna, and Bernstein have adjusted their ratings and price targets, mostly lowering them. APA, an independent exploration and production company, has faced a revenue decline of -20.06% over the past 3 months but has strong profitability indicators such as a net margin of 19.89% and ROE of 51.37%. However, the company has a high debt-to-equity ratio of 5.28, indicating potential financial strain.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 6:00 pm

APA

Raymond James analyst John Freeman has maintained a Strong Buy rating on APA Corporation (NASDAQ:APA) but reduced the price target from $61 to $44. This adjustment reflects a more conservative valuation of APA's stock.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 5:56 pm

ALTM

Raymond James analyst Pavel Molchanov has maintained an Outperform rating on Arcadium Lithium (NYSE:ALTM) but reduced the price target from $30 to $11.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 5:54 pm